Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer

MLA

Hall, Peter S., et al. “Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer.” JAMA Oncology, May 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........214e90c69ab899b6a61145b62d66f8eb&authtype=sso&custid=ns315887.

APA

Hall, P. S., Swinson, D., Cairns, D. A., Waters, J. S., Petty, R., Allmark, C., Ruddock, S., Falk, S., Wadsley, J., Roy, R., Tillett, T., Nicoll, J., Cummins, S., Mano, J., Grumett, S., Stokes, Z., Konstantinos-Velios, K., Chatterjee, A., Garcia, A., … Seymour, M. T. (2021). Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer. JAMA Oncology.

Chicago

Hall, Peter S., Daniel Swinson, David A. Cairns, Justin S. Waters, Russell Petty, Christine Allmark, Sharon Ruddock, et al. 2021. “Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer.” JAMA Oncology, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........214e90c69ab899b6a61145b62d66f8eb&authtype=sso&custid=ns315887.